REDWOOD CITY, Calif.--()--Suki, the leader in artificial intelligence (AI) technology for healthcare, today announced an investment from Zoom Ventures, the investment arm of the AI-first work platform and leading healthcare collaboration platform, Zoom Communications, Inc. Suki will join Zoom Ventures’ portfolio of AI investments, which includes Anthropic and CoreWeave. Building upon Suki’s $70 million Series D raise announced in October, the company has now raised $168 million to date. Today’s announcement follows Suki’s Platform partnership with Zoom to integrate AI-driven clinical notes into Zoom's Workplace for Clinicians solution, designed to improve user experience and patient care.

"In 2024, Suki experienced remarkable growth, expanding 4x in only 12 months. This next phase is driven by our latest investments and the expanding opportunities within our addressable market, with technology leaders like Zoom seeking new ways of collaborating with us. Our shared values and goals have enabled us to revolutionize the healthcare experience for clinicians and patients nationwide with AI," said Punit Soni, CEO and Founder of Suki. "This new capital allows us to scale our technology, offering new capabilities to our customers, and we're grateful for the opportunity to expand the strong team we've built over the last seven years. It's truly a testament to the impact Suki Assistant and Suki Platform have on the health systems and technology companies we partner with."

"We are excited to deepen our partnership with Suki with this investment. Suki's turnkey solutions enable health systems to seamlessly adopt AI-powered tools to improve productivity and healthcare outcomes. This technology helps power Zoom's healthcare offerings and aligns with our mission of leveraging AI to drive employee productivity and enhance patient experiences. Suki's exceptional growth and widespread adoption within healthcare systems highlights the tremendous value their solutions bring to the healthcare industry.” said Ricardo Anzaldua, Head of Corporate Development and Zoom Ventures.

This investment also comes on the heels of Suki’s partnership with technology giant Google last month, which solidified Suki’s position as the industry's first end-to-end clinical AI assistant. By leveraging Google Cloud’s Vertex AI platform, Suki introduced new features like patient summaries and Q&A to expedite the clinical decision-making process and reduce information overload for clinicians.

The company has grown exponentially, accelerated by its Series D raise, which enabled Suki to scale its technology and AI capabilities to better support healthcare collaboration partners like Zoom. As part of this new growth phase, the company adds three new executives to strengthen its leadership team.

Demetra Airaudi, Senior Vice President of Marketing

Suki hires its first SVP of Marketing, Demetra Airaudi. Airaudi joins Suki after two decades of marketing and communications experience with major technology companies, including holding senior positions at Block (formerly Square), Skype, Microsoft, LG Mobile Phones U.S., and most recently at Navan. With a deep understanding and experience in brand and communications, Airaudi will oversee Suki's marketing organization.

Aden Fine, General Counsel

As policies on AI come to the forefront following the new administration's inauguration, Fine brings over 25 years of experience navigating regulation and novel policy issues for healthcare and technology companies like Datavant and Edmodo, where he served as General Counsel and Chief Privacy Officer. Fine, who also spent ten years working on technology and privacy issues for the American Civil Liberties Union, will also lead Suki’s People team.

Jonathan Antonio, Vice President of Infrastructure

Jojo Antonio steps into Suki to lead site reliability engineering (SRE/DevOps), security, compliance, and information technology (IT). Having worked at companies including Twitter, Google, YouTube, and PayPal, as VP of Infrastructure, Antonio will maintain Suki’s HIPAA compliance and SOC2 Type 2 certification standards as it expands partnerships with new health systems and leading technology companies. He will also strengthen the company’s infrastructure to support scale in this massive growth phase.

Suki Assistant is used by 350 health systems and clinics across the country. Suki Assistant offers summaries of patient medical records, answers medical reference questions, documentation, coding, retrieval of patient chart data, and dictation. Suki’s breadth of features has contributed to its industry-leading adoption rate across its client base and its Platform partnerships with leading technology companies like Epic, Zoom, athenahealth, MEDITECH, Azalea Health, MEDENT, and more. Suki Platform is the defacto AI engine of healthcare. To learn more about Suki, visit www.suki.ai.

About Suki

Suki is a leading technology company that provides AI voice solutions for healthcare. Its mission is to reimagine the healthcare technology stack, making it invisible and assistive to lift the administrative burden from clinicians. Its flagship product is Suki Assistant, an AI assistant that uses generative AI to automatically create clinical documentation by ambiently listening to patient-clinician conversations. Suki helps clinicians complete notes 72% faster on average, assists with other tasks including coding and answering questions, and generates incremental revenue for organizations, delivering a 9X ROI in year 1. Suki also offers its proprietary AI and speech platform, Suki Platform, to partners who want to create best-in-class ambient and voice experiences for their solutions. Suki is backed by premier investors such as Venrock, First Round, Flare Capital Partners, March Capital, and Breyer Capital. To learn more, visit suki.ai, or follow us on LinkedIn and Twitter.